| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26487-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26401-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21559-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18097-500ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-14161 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-21141 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-24327 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20900 | |||
![Immunocytochemistry/Immunofluorescence: Aurora A Antibody (1H8) [NBP3-26487] - Staining of Hela Cells with Aurora A Antibody (1H8) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeated by 0.2% Triton X-100, and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. Nuclear DNA was labeled in blue with DAPI. The secondary antibody was FITC-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26487_rabbit-aurora-a-mab-1h8-282202412493636.jpg "Immunocytochemistry/Immunofluorescence: Aurora A Antibody (1H8) [NBP3-26487] - Staining of Hela Cells with Aurora A Antibody (1H8) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeated by 0.2% Triton X-100, and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. Nuclear DNA was labeled in blue with DAPI. The secondary antibody was FITC-conjugated Goat Anti-Rabbit IgG (H+L).")
![Western Blot: AMPK alpha 2 [p Ser491] Antibody (3H10) [NBP3-26401] - Positive Western Blot detected in 293 whole cell lysate. A549 whole cell lysate. All lanes: AMPK alpha 2 [p Ser491] Antibody at 1.1ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 62 KDa Observed band size: 62 KDa](http://images.novusbio.com/fullsize/nbp3-26401_rabbit-ampk-alpha-2-p-ser-491-mab-3h10-28220241135169.jpg "Western Blot: AMPK alpha 2 [p Ser491] Antibody (3H10) [NBP3-26401] - Positive Western Blot detected in 293 whole cell lysate. A549 whole cell lysate. All lanes: AMPK alpha 2 [p Ser491] Antibody at 1.1ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 62 KDa Observed band size: 62 KDa")
![Western Blot: MEK1 [p Thr 292] Antibody (SR1773) [NBP3-21559] - Western blot analysis using NBP3-21559 in (1) HeLa cell lysate; (2) HeLa cell treated with Nocodazole.](http://images.novusbio.com/fullsize/nbp3-21559_rabbit-mek1-p-thr-292-mab-sr1773-57202317215122.jpg "Western Blot: MEK1 [p Thr 292] Antibody (SR1773) [NBP3-21559] - Western blot analysis using NBP3-21559 in (1) HeLa cell lysate; (2) HeLa cell treated with Nocodazole.")
![Flow Cytometry: CD45RA Antibody (B-C15) - Azide and BSA Free [NBP3-18097] - A typical staining pattern with the B-C15 monoclonal antibody of lymphocytes.](http://images.novusbio.com/fullsize/CD45RA-Antibody-B-C15-Azide-and-BSA-Free-Flow-Cytometry-NBP3-18097-img0001.jpg "Flow Cytometry: CD45RA Antibody (B-C15) - Azide and BSA Free [NBP3-18097] - A typical staining pattern with the B-C15 monoclonal antibody of lymphocytes.")
![Immunohistochemistry-Paraffin: CD45RA Antibody (PTPRC/7019R) [NBP3-13758] - Formalin-fixed, paraffin-embedded human tonsil stained with CD45RA antibody (PTPRC/7019R). Inset: PBS instead of primary antibody; secondary only negative control.](http://images.novusbio.com/fullsize/CD45RA-Antibody-PTPRC-7019R-Immunohistochemistry-Paraffin-NBP3-13758-img0001.jpg "Immunohistochemistry-Paraffin: CD45RA Antibody (PTPRC/7019R) [NBP3-13758] - Formalin-fixed, paraffin-embedded human tonsil stained with CD45RA antibody (PTPRC/7019R). Inset: PBS instead of primary antibody; secondary only negative control.")
